Table 1.
Country | National AMR plan | Surveillance on antimicrobial use and resistance | Access to quality essential medicines | Rational medicine use | IPC | Innovation, research and development |
---|---|---|---|---|---|---|
Total (47) | 2 | 0 | 44 | 43 | 7 | 0 |
% | 4.3 | 0.0 | 93.6 | 91.5 | 14.9 | 0.0 |